G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery.

[1]  H. Lother,et al.  Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension , 2007, Journal of Molecular Neuroscience.

[2]  K. Fuxe,et al.  Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases , 2007, NeuroMolecular Medicine.

[3]  N. Nathanson,et al.  Quantitative Analysis of Muscarinic Acetylcholine Receptor Homo- and Heterodimerization in Live Cells , 2006, Journal of Biological Chemistry.

[4]  K. L. Martinez,et al.  FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Milligan,et al.  Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD , 2006, Molecular Pharmacology.

[6]  M. Vivó,et al.  Investigation of Cooperativity in the Binding of Ligands to the D2 Dopamine Receptor , 2006, Molecular Pharmacology.

[7]  A. Ayala,et al.  Pepducins: an effective means to inhibit GPCR signaling by neutrophils. , 2005, Trends in immunology.

[8]  Marta Filizola,et al.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  David J. Daniels,et al.  Interaction of Bivalent Ligand KDN21 with Heterodimeric δ-κ Opioid Receptors in Human Embryonic Kidney 293 Cells , 2005, Molecular Pharmacology.

[10]  N. Alenina,et al.  Evidence for a Functional Interaction of the Angiotensin-(1–7) Receptor Mas with AT1 and AT2 Receptors in the Mouse Heart: P220 , 2005, Hypertension.

[11]  G. Milligan,et al.  Functional Complementation and the Analysis of Opioid Receptor Homodimerization , 2005, Molecular Pharmacology.

[12]  C. Hague,et al.  Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance , 2005, Pharmacological Reviews.

[13]  Graeme Milligan,et al.  The CXCR1 and CXCR2 Receptors Form Constitutive Homo- and Heterodimers Selectively and with Equal Apparent Affinities* , 2005, Journal of Biological Chemistry.

[14]  E. Lakatta,et al.  Heterodimerization of β1- and β2-Adrenergic Receptor Subtypes Optimizes β-Adrenergic Modulation of Cardiac Contractility , 2005 .

[15]  J. Pelletier,et al.  High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based β-Arrestin2 Recruitment Assay , 2005, Journal of biomolecular screening.

[16]  T. Lazarova,et al.  Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor , 2005, Protein science : a publication of the Protein Society.

[17]  K. Palczewski,et al.  Diversifying the repertoire of G protein-coupled receptors through oligomerization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Jamie Fong,et al.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Whistler,et al.  An Opiate Cocktail that Reduces Morphine Tolerance and Dependence , 2005, Current Biology.

[20]  Michel Bouvier,et al.  Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.

[21]  Xiaochun Sun,et al.  Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer , 2005, Molecular Pharmacology.

[22]  F. Giorgi,et al.  Paired Activation of Two Components within Muscarinic M3 Receptor Dimers Is Required for Recruitment of β-Arrestin-1 to the Plasma Membrane* , 2005, Journal of Biological Chemistry.

[23]  P. Slocombe,et al.  Analysis of endogenous S1P and LPA receptor expression in CHO-K1 cells. , 2005, Gene.

[24]  P. Sexton,et al.  G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor , 2005, Circulation.

[25]  H. Loh,et al.  Heterodimerization of μ- and δ-Opioid Receptors Occurs at the Cell Surface Only and Requires Receptor-G Protein Interactions* , 2005, Journal of Biological Chemistry.

[26]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[27]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[28]  M. von Zastrow,et al.  The Composition of the β-2 Adrenergic Receptor Oligomer Affects Its Membrane Trafficking after Ligand-Induced Endocytosis , 2005, Molecular Pharmacology.

[29]  Krzysztof Palczewski,et al.  Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.

[30]  J. L. Hansen,et al.  Functional consequences of 7TM receptor dimerization. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  Michel Bouvier,et al.  Real-time monitoring of ubiquitination in living cells by BRET , 2004, Nature Methods.

[32]  Vladislav V Verkhusha,et al.  Three-chromophore FRET microscopy to analyze multiprotein interactions in living cells , 2004, Nature Methods.

[33]  Jonathan A Javitch,et al.  The Ants Go Marching Two by Two: Oligomeric Structure of G-Protein-Coupled Receptors , 2004, Molecular Pharmacology.

[34]  G. Milligan,et al.  Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-Adrenoceptor , 2004, Molecular Pharmacology.

[35]  Graeme Milligan,et al.  Domain Swapping in the Human Histamine H1 Receptor , 2004, Journal of Pharmacology and Experimental Therapeutics.

[36]  B. O'dowd,et al.  Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal* , 2004, Journal of Biological Chemistry.

[37]  J. W. Wells,et al.  Oligomeric potential of the M2 muscarinic cholinergic receptor , 2004, Journal of neurochemistry.

[38]  M. Bouvier,et al.  Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties* , 2004, Journal of Biological Chemistry.

[39]  K. Fuxe,et al.  Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. , 2004, Parkinsonism & related disorders.

[40]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[41]  J. L. Hansen,et al.  Oligomerization of Wild Type and Nonfunctional Mutant Angiotensin II Type I Receptors Inhibits Gαq Protein Signaling but Not ERK Activation* , 2004, Journal of Biological Chemistry.

[42]  Rasmus Jorgensen,et al.  Development of a BRET2 Screening Assay Using β-Arrestin 2 Mutants , 2004 .

[43]  A. Engel,et al.  The G protein‐coupled receptor rhodopsin in the native membrane , 2004, FEBS letters.

[44]  Lakshmi A. Devi,et al.  A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia , 2004 .

[45]  H. Lother,et al.  AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. , 2004, Seminars in nephrology.

[46]  L. Buck,et al.  The human olfactory receptor gene family. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Michel Bouvier,et al.  Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Mei Bai,et al.  Dimerization of G-protein-coupled receptors: roles in signal transduction. , 2004, Cellular signalling.

[49]  Gerda E Breitwieser,et al.  G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. , 2004, Circulation research.

[50]  T. Kenakin.  G-protein coupled receptors as allosteric machines. , 2004, Receptors & channels.

[51]  R. Moon,et al.  Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization , 2004, Nature Cell Biology.

[52]  K. Blumer,et al.  Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor* , 2003, Journal of Biological Chemistry.

[53]  A. Kuliopulos,et al.  Blocking receptors on the inside: pepducin-based intervention of PAR signaling and thrombosis. , 2003, Life sciences.

[54]  Francesca Fanelli,et al.  Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization , 2003, Journal of Biological Chemistry.

[55]  M. Millan,et al.  Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole , 2003, Journal of neurochemistry.

[56]  P. Seeman,et al.  Blockade of G Protein-Coupled Receptors and the Dopamine Transporter by a Transmembrane Domain Peptide: Novel Strategy for Functional Inhibition of Membrane Proteins in Vivo , 2003, Journal of Pharmacology and Experimental Therapeutics.

[57]  Graeme Milligan,et al.  Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins* , 2003, Journal of Biological Chemistry.

[58]  J. Klco,et al.  C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.

[59]  Terry Kenakin,et al.  Ligand-selective receptor conformations revisited: the promise and the problem. , 2003, Trends in pharmacological sciences.

[60]  Graeme Milligan,et al.  High-content assays for ligand regulation of G-protein-coupled receptors. , 2003, Drug discovery today.

[61]  Pierre Casellas,et al.  Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor , 2003, Journal of Biological Chemistry.

[62]  Joseph Parello,et al.  Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.

[63]  Krzysztof Palczewski,et al.  Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.

[64]  P. Molinari,et al.  Promiscuous Coupling at Receptor-Gα Fusion Proteins , 2003, The Journal of Biological Chemistry.

[65]  M. Mortrud,et al.  The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Susan R. George,et al.  G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.

[67]  Graeme Milligan,et al.  Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. , 2002, The Biochemical journal.

[68]  J. W. Wells,et al.  Cooperativity and oligomeric status of cardiac muscarinic cholinergic receptors. , 2002, Biochemistry.

[69]  Jamie Fong,et al.  Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization , 2002, Cell.

[70]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[71]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Lakshmi A Devi,et al.  Opioids and Their Complicated Receptor Complexes , 2000, Neuropsychopharmacology.

[73]  D. Jenness,et al.  Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis. , 2000, Molecular biology of the cell.

[74]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[75]  Y. Jan,et al.  A New ER Trafficking Signal Regulates the Subunit Stoichiometry of Plasma Membrane KATP Channels , 1999, Neuron.

[76]  C Higgs,et al.  Domain swapping in G-protein coupled receptor dimers. , 1998, Protein engineering.

[77]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.